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Abstract 
 
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that causes the immune 
system to attack the body’s own connective tissues and organs. Humans have difficulty predicting SLE 
symptom severity levels because of the complex interactions of disease trigger exposure levels over time. 
To address this issue, we constructed a novel machine learning solution that generates a model capable of 
predicting SLE symptom severity levels with 8.3-19.9% average error. It does so by inputting trigger 
exposure levels into a recursive neural network and training them with a unique method that continually 
turns training on and off based on the maximum error each day. This allows the RNN to learn SLE flare 
activity without overtraining remission activity, thus maintaining a greater degree of plasticity. Models 
trained in this fashion performed 3.5-5% better on average than those trained via the standard method. 
Future areas of work include replicating these results with a large patient training data set and evolving the 
model to predict disease trajectory.  
Introduction 
 
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that causes the immune 
system to attack the body’s own connective tissues and organs. It is a serious and potentially life-
threatening illness that affects roughly five million people around the world (Lupus Foundation of America, 
2018). Humans have difficulty predicting SLE symptom severity levels because of the complex interactions 
of disease trigger exposure levels over time. SLE symptom severity levels continuously fluctuate in 
response to the individuals’ sensitivity and exposure to disease triggers, such as activity and stress level, 
UV exposure, amount of sleep, illness and injury. To manage their symptoms, SLE patients must 
understand and limit their exposure to these triggers. Because of their complex interactions over time, 
however, this is not a simple task.  
For example, an individual may be able to safely tolerate three hours of UV exposure when well-
rested and relaxed. If they have other compounding trigger exposures, however, the same about of UV 
exposure may cause them to develop a rash. Additionally, the same amount of trigger exposure can cause 
different reactions depending on the amount of exposure experienced the previous days. This is not only 
true for the same trigger, but others as well. This means that the same three hours of UV exposure when 
relaxed could cause a reaction if the previous day the individual was extremely stressed. 
This complexity can make SLE feel unpredictable, unmanageable and frightening to sufferers. 
“With symptoms that come and go, disease flares and remissions, and the uncertainty of what each day will 
bring, it’s normal to experience feelings of unhappiness, frustration, anger, or sadness” (Lupus Foundation 
of America, 2018). This emotional tole can become debilitating. Studies show that between 15 and 60 
percent of people with a chronic illness like SLE will experience clinical depression during the course of 
their disease (Lupus Foundation of America, 2018).  
A tool that is able to predict SLE symptom severity levels with a greater accuracy than humans is 
one way to reduce this burden. By identifying and illuminating patterns in trigger exposure and symptom 
severity levels, such a tool would also improve SLE patients’ ability to manage their symptoms. This would 
have profound and wide-ranging effects. Better symptom management has been shown to increase patient 
quality of life, reduce healthcare costs, and improve disease prognosis (Lupus Foundation of America, 
2018). 
Background and Related Work 
 
Machine learning is an emerging field in computer science that seeks to solve complex problems 
like the one posed by SLE. Because there are many trigger exposure levels that interact to result in many 
symptom severity levels, the problem is well suited to a specific type of machine learning architecture 
known as an artificial neural network (Fausett, 1994).  
Artificial neural networks are a type of computing system inspired by the biological neural 
networks that constitute animal brains (Fausett, 1994). They are comprised of layers of nodes with 
weighted connections between them that are meant to immitate neurons (Fausett, 1994). In their simplest 
execution, data is loaded into the input layer nodes, filtered through the network, and outputed via the 
output layer nodes (Fausett, 1994).  
There are many unique forms that artificial neural networks can take to improve their performance 
in different problem domains. In one structure, called a recursive neural network (RNN), the previous 
step’s output values are reentered into the net as input values for the next step (Fausett, 1994). This is 
useful for problems like SLE symptom prediction in which previous outputs influence future predictions.  
Context units are another type of structure that allow neural networks to account for history-
sensitive variance (Fausett, 1994). A special type of input node, these units receive their data from the 
previous steps’ hidden layer nodes and reinsert it into the net during the next step. This injects historical 
input data into the equation (Fausett, 1994).        
We hypothesized that an artificial neural network could successfully predict SLE symptom levels 
because it has been used successfully for other disease symptom prediction problems (Wu, Roy, & Stewart, 
2010). The specific form of an RNN with context units was selected due to its proven ability to account for 
historical input and output data in a variety of problem domains (Fausett, 1994). This allows it to account 
for the influence of historical trigger exposure and symptom severity levels in its predictions. 
Existing medical machine learning studies have used a similar time series approach, such as 
Wiens, Guttag, and Horvitz’s (2012) work predicting patient risk of hospital-acquired infection. The 
current body of work is limited, however, in its application to SLE.  
Existing machine learning studies addressing SLE treatment are focused on clustering problems, 
such as identifying the genes responsible for SLE (Armañanzas et al., 2009) and risk factors for specific 
adverse SLE outcomes  (Ravenell et al., 2012). These studies utilize quantitative data, such as DNA, that is 
collected and analyzed in a laboratory setting. We did not find any SLE studies that utilized or predicted 
subjective patient data such as fatigue and pain levels.  
This deficit is likely due to the difficulties associated with the accurate elicitation and 
normalization of subjective health data for use in computer algorithms. While gathering daily symptom 
level reports, we have found that factors such as emotional state and personality greatly impact reported 
values. This negatively affects the predictive ability of models that use the data. The inability to correct for 
this issue is a significant weakness in the current body of knowledge, because it greatly limits what aspects 
of SLE can be effectively studied. 
Program Requirements 
 
 To begin to fill the existing knowledge gaps, we have designed, implemented, trained and tested 
an RNN for SLE symptom prediction based on historic disease trigger exposure and symptom severity 
levels. We hypothesized that this was possible because machine learning has been used successfully for 
other disease symptom prediction problems (Wu, Roy, & Stewart, 2010).  The model produced shows that, 
though humans struggle to predict SLE symptoms, they are based on a pattern of trigger exposure 
interactions that is machine learnable. 
The model is able to memorize a year of artificial SLE data to a roughly 20% degree of accuracy. 
This proves that, though humans struggle to predict SLE symptoms, they are based on a pattern of trigger 
exposure interactions that is machine learnable. Interestingly, the model memorizes actual patient data sets 
more accurately than it does the artificial data sets. This suggests that there may be conflicting data in the 
artificial sets that was accidentally injected in the construction process. If this hypothesis is true, it means 
that the problem is even more well suited to a machine learning solution than is evident by our results. 
The model produced by the standard train/validate process, however, is too rigid to perform well 
on diverse and fluctuating SLE presentations.  SLE includes hallmark disease flare and remission cycles, 
and the remission periods were being over-trained though the flares were under-trained. This led us to 
construct a second, novel training method for the RNN that is more performant in this disease domain.  It 
continually turns training on and off based on the maximum error each day. When triggered on, the RNN 
retrains over the past 30 days before continuing training new incoming data. In this way, the RNN is able to 
learn the SLE flare activity without overtraining the remission activity.  
Because SLE is a rapidly shifting disease, the new model’s rate of change is also significantly 
increased, allowing it to react quickly to a slowly incoming data set. In our study, models trained in this 
fashion performed 3.5 to 5% better on average than those trained via standard memorization. Although a 
synthesized training data set was used because of data access limitations, the models generated were 
accurate on both small real patient data sets. In the future, we would like to replicate these results with a 
large SLE training data set. 
Implementation 
 
The RNN built is composed of a five-node input layer with two recursive inputs and ten context 
units, a ten-node hidden layer, and a two-node output layer (see Appendix A). The patient’s daily stress 
level, activity level, UV exposure, hours of sleep, and illness or injury level are entered into the network. 
The model outputs predicted fatigue and rash levels. The actual values of these symptoms are then entered 
and used the following day as the recursive inputs. If it is in training mode, error is calculated and 
backpropagated through the RNN.  
 Training a machine learning algorithm requires large data sets (Fausett, 1994). Because of limited 
access to patient data, we built large training and testing data sets using artificially constructed patient data. 
The accuracy of these sets was reviewed by an SLE patient and verified in the model via their predictive 
capacity on two small SLE patient data sets.   
 The original concept for this project was an iOS application for SLE patients that would allow 
them to enter trigger exposure levels and get predicted symptom levels. Within the first weeks of the 
project, however, we realized that this prediction could only be accomplished via machine learning due to 
the complex interaction of trigger exposure levels over time. Never having studied machine learning 
before, we decided to implement the RNN without external machine learning libraries so that we could 
better learn and understand what it was doing and to accommodate our novel training model. 
 External machine learning libraries such as TenserFlow were considered and may be used in 
subsequent prototypes. Independently building the model, however, had significant academic value. It 
allowed us to apply the new information we were learning in a hands-on way, and it revealed points of 
confusion. For example, several misunderstandings were made evident when we attempted to implement 
the backpropagation method, including how the values were being calculated and where the signals were 
being sent. These would not have come to light and been corrected if we had simply made a function call to 
an external library. 
Results, Evaluation, and Reflection 
 
 This project is an initial prototype into a complex and previously unexplored problem space. It 
faced substantial time and data availability limitations, and it was a stretch of our academic abilities. As 
such, the results are significant for several reasons. 
 First, the model’s ability to memorize the artificial and SLE data sets indicates that SLE symptom 
severity levels are based on a pattern of trigger exposure interactions that is machine learnable. This opens 
the door to further machine learning research into their relationship and prediction. This discovery was able 
to be made despite limited access to SLE patient data because we spent considerable time building and 
testing artificial data sets that could be used to train and test the RNN.  
 Second, we were able to construct a novel training method that is 3.5-5% more effective than the 
standard method because we took the time to construct the RNN from scratch instead of using existing 
libraries. This allowed us to learn exactly how the RNN was working (despite being new to machine 
learning research), which revealed the issues with the standard model. Further work is needed to reduce the 
average error as much as possible. 
 Finally, the end result represents a profound amount of self-directed independent learning. 
Undertaking it was our first exposure to machine learning concepts, and yet we were able to construct a 
working prototype that is reasonably accurate within the space of a single semester.  
If enough patient data had been available to train and test the RNN without artificial data sets, and 
the same results were achieved, this would be publication-worthy work. It pushes the bounds of SLE 
machine learning research and proves that further exploration is likely to be fruitful. Most importantly, it 
provides a working predictive model which SLE patients can use to manage their symptoms. 
Conclusions and Future Work 
 
The most valuable outcome of the model is the actionable information it provides to physicians 
and patients. Though still in its infancy, it already shows promise for symptom management. The next step 
is replicating the experiment only using real patient data. Large volumes of data from a wide variety of SLE 
patients is necessary to improve the model’s accuracy and plasticity. We suggest using data from at least 50 
different SLE patients. Specific attention should be given to increasing the model’s ability to recognize 
disease flares. It is important to also test the full range of disease triggers and symptoms in the RNN to 
form a complete real-world model. Such data is available through existing medical and pharmaceutical 
organizations currently engaged in SLE research. 
In addition to improving the model, we are working to evolve it to not only predict outcomes but 
also direct patients using behavior modification feedback, guiding them into a desired disease state. Fox, 
Ang, Jaiswal, Pop-Busui, and Wiens’ (2018) recently proved in a similar disease symptom trajectory 
problem that machine learning is effective for multi-step forecasting, indicating that this is likely possible 
for SLE as well. Using this disease path prediction, future programs could direct patients to avoid specific 
trigger exposures when they are straying from the desired disease course. 
If successful, this research would be life changing for patients with SLE and similar disorders. 
Behavioral coaching for chronic disease self-care is financially out of reach for most patients. An 
accessible digital version, such as a machine learning-powered app, would allow for greater access to this 
type of care and improved outcomes.  
Such an application would not be useful, however, if it did not come with a pretrained model. 
Further research should consider the ways in which a model or set of models can be constructed for initial 
use, then honed to the specific disease presentation of each user. This would likely involve machine 
learning research examining the possible identification of unique SLE subtypes.  
Future work should also consider ways in which the need for manual data entry can be reduced 
without reducing the model’s predictive capacity. This may include the automatic uploading of medical test 
results, activity monitors, and related health information. Ranking the usefulness of input variables and 
eliminating those with the least influence may also help reduce the burden on users. 
Finally, this project revealed significant limitations caused by the use of subjective health data, 
such as fatigue and pain levels, in machine learning. Further work should examine the accurate elicitation 
and normalization of subjective health data for use in computer algorithms. Detecting and accounting for 
these issues could improve the predictive abilities of models that rely on the data, like the one described 
here.  
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Appendix A 
 
 
 
 
Architecture of 5 input, 2 output neural network with input units (X1-X10), recursive input units (R1-R2), 
context units (C1-C10), hidden units (Z1-Z10), & output units (Y1-Y2). 
 
 
